Silo Pharma (SILO) Competitors $0.45 -0.04 (-8.84%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.46 +0.01 (+2.13%) As of 05/21/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, MGOL, EVKG, LULU, ONON, AS, BIRK, GIL, LEVI, and BRPShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), MGO Global (MGOL), Ever-Glory International Group (EVKG), Lululemon Athletica (LULU), ON (ONON), Amer Sports (AS), Birkenstock (BIRK), Gildan Activewear (GIL), Levi Strauss & Co. (LEVI), and The Baldwin Insurance Group (BRP). These companies are all part of the "apparel" industry. Silo Pharma vs. Perfect Moment MGO Global Ever-Glory International Group Lululemon Athletica ON Amer Sports Birkenstock Gildan Activewear Levi Strauss & Co. The Baldwin Insurance Group Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings, profitability and community ranking. Do institutionals & insiders have more ownership in PMNT or SILO? 23.0% of Perfect Moment shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 4.4% of Silo Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media favor PMNT or SILO? In the previous week, Silo Pharma had 8 more articles in the media than Perfect Moment. MarketBeat recorded 8 mentions for Silo Pharma and 0 mentions for Perfect Moment. Silo Pharma's average media sentiment score of 0.68 beat Perfect Moment's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the news media. Company Overall Sentiment Perfect Moment Neutral Silo Pharma Positive Which has more risk and volatility, PMNT or SILO? Perfect Moment has a beta of -3.22, meaning that its share price is 422% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Do analysts prefer PMNT or SILO? Perfect Moment presently has a consensus price target of $6.00, suggesting a potential upside of 811.85%. Given Perfect Moment's stronger consensus rating and higher possible upside, research analysts plainly believe Perfect Moment is more favorable than Silo Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Silo Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is PMNT or SILO more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -5,255.05%. Silo Pharma's return on equity of -61.38% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Perfect Moment-67.38% -513.83% -119.38% Silo Pharma -5,255.05%-61.38%-47.49% Does the MarketBeat Community favor PMNT or SILO? Perfect Moment and Silo Pharma both received 1 outperform votes by MarketBeat users. CompanyUnderperformOutperformPerfect MomentOutperform Votes1100.00% Underperform VotesNo VotesSilo PharmaOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation and earnings, PMNT or SILO? Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Perfect Moment is trading at a lower price-to-earnings ratio than Silo Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerfect Moment$21.31M0.51-$8.72M-$1.30-0.51Silo Pharma$72.10K27.71-$3.70M-$1.17-0.38 SummarySilo Pharma beats Perfect Moment on 10 of the 16 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.00M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-0.388.9226.8419.71Price / Sales27.71253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.216.466.794.50Net Income-$3.70M$143.98M$3.23B$248.18M7 Day Performance-46.71%3.04%4.07%1.14%1 Month Performance-57.97%7.44%12.52%15.20%1 Year Performance-79.56%-2.46%16.83%6.56% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.3311 of 5 stars$0.45-8.8%N/A-79.6%$2.00M$72,102.00-0.382News CoveragePMNTPerfect MomentN/A$0.85-2.0%$6.00+605.9%-77.8%$14.08M$21.31M-0.6531Gap UpMGOLMGO GlobalN/A$0.31-33.8%N/A-97.5%$894,000.00$5.20M-0.077Gap DownHigh Trading VolumeEVKGEver-Glory International GroupN/A$0.00flatN/A-12.5%$10,000.00N/A0.004,300LULULululemon Athletica3.7424 of 5 stars$310.16+2.0%$368.72+18.9%-1.7%$37.42B$10.59B22.3929,000ONONON2.664 of 5 stars$57.38+11.8%$58.18+1.4%+58.6%$36.13B$2.32B133.441,160High Trading VolumeASAmer Sports3.194 of 5 stars$31.31+4.2%$31.45+0.5%+149.5%$17.34B$5.18B-223.6311,400Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap UpBIRKBirkenstock3.2271 of 5 stars$54.47+2.2%$66.06+21.3%+15.7%$10.23B$1.86B43.937,400Earnings ReportAnalyst ForecastGILGildan Activewear4.6583 of 5 stars$49.12+1.4%$58.20+18.5%+35.9%$7.44B$3.29B19.6551,000News CoveragePositive NewsLEVILevi Strauss & Co.3.5385 of 5 stars$17.84+0.6%$19.45+9.1%-21.2%$7.06B$6.40B34.3118,000Trending NewsAnalyst ForecastBRPThe Baldwin Insurance GroupN/A$39.37+1.4%$37.00-6.0%+13.7%$4.63B$1.27B-42.799,200 Related Companies and Tools Related Companies Perfect Moment Competitors MGO Global Competitors Ever-Glory International Group Competitors Lululemon Athletica Competitors ON Competitors Amer Sports Competitors Birkenstock Competitors Gildan Activewear Competitors Levi Strauss & Co. Competitors The Baldwin Insurance Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.